Dr. Walter G. Copan – Congressional Testimony: The State of U.S. Science and Technology: Ensuring U.S. Global Leadership

On February 5th, 2025, Dr. Walter G. Copan testified before the House Committee on Science, Space, and Technology on the State of U.S. Science and Technology: Ensuring U.S. Global Leadership.

Copan, Vice President for Research and Technology Transfer at the Colorado School of Mines, former Director of the National Institute of Standards and Technology (NIST), and CSIS Senior Adviser, emphasized the crucial role of investment in public-sector R&D, as well as STEM education and workforce training.

“Two decades ago, the United States was the undisputed global leader in science and technology, and in driving innovation for economic value creation. Today, however, by many internationally recognized measures, America’s global leadership position in the majority of the critical technology fields has been overtaken by China.”

“We are in a period where crisis presents America with great opportunity. The U.S. must take a new strategic approach to the future of research and S&T advancement that engages across government agencies. We must leverage collaboration and investments with the private sector, bolster education at all levels, and engage with our national R&D, intellectual property, standards and innovation enterprise. We have the chance to drive great synergies in federal R&D investment, through a national S&T and innovation strategy.”

Watch the full hearing here, and read Dr. Copan’s opening remarks here.

Protecting Intellectual Property for National Security: A Transition Report for the New Administration

By Kirti Gupta, Andrei Iancu, Walter G. Copan, and Chris Borges This report was originally published on March 26th with CSIS. Download the full report here. Executive Summary The United States is undergoing a generational shift in how economic policy intersects with national security. Decades of globalization have exposed
Read More

The United States Cannot Afford Disarray as China Strengthens Its Biopharmaceutical Industry

By Sujai Shivakumar, Charles Wessner, and Julie Heng For years, China has played a leading role in manufacturing active pharmaceutical ingredients and generic drugs. While securing the supply chain for active pharmaceutical ingredients is increasingly recognized as a national security priority by policymakers, China’s growing role in biotechnological innovation has
Read More

Explainer: A Brief History of the International IP Regime

By Julie Heng, Arrizka Faida, and Chris Borges In a globalized economy, businesses rely on rules protecting intellectual property (IP) to safeguard their ideas and products against counterfeiting, piracy, and theft and to forge international partnerships. To this end, the United States and its partners have long invested in a system of multilateral treaties and international
Read More